| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |